Clear Harbor Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Clear Harbor Asset Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$285K	Sell	969 -3,629	-79%	-$1.03M	0.02%	373
2026 Q1	$1.28M	Buy	4,598 +2,179	+90%	+$628K	0.09%	179
2025 Q4	$733K	Buy	2,419 +885	+58%	+$276K	0.05%	253
2025 Q3	$430K	Sell	1,534 -425	-22%	-$116K	0.03%	307
2025 Q2	$473K	Sell	1,959 -391	-17%	-$92.4K	0.04%	282
2025 Q1	$572K	Buy	+2,350	New	+$707K	0.05%	245

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Clear Harbor Asset Management's BIO Position: Q2 2026 in Review

Clear Harbor Asset Management reduced its Bio-Rad Laboratories Class A (BIO) stake by 79% in Q2 2026, selling an estimated $1.03M and leaving 969 shares worth $285K. The position accounts for 0.02% of the portfolio, ranked #373.

Clear Harbor Asset Management first reported a position in BIO in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.28M in Q1 2026. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Clear Harbor Asset Management held 969 shares of Bio-Rad Laboratories Class A worth $285K as of Q2 2026.
Clear Harbor Asset Management sold 3,629 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $1.03M.
Bio-Rad Laboratories Class A made up 0.02% of Clear Harbor Asset Management's portfolio in Q2 2026, its #373 holding.
Clear Harbor Asset Management first reported a position in Bio-Rad Laboratories Class A in Q1 2025 and has held it in 6 quarters since.
Clear Harbor Asset Management's Bio-Rad Laboratories Class A position peaked at $1.28M in Q1 2026.
400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.